BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 998155 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccc2nccc(C(N)=O)c2c1 InChI=1S/C24H21N5O/c1-13-3-2-4-20(27-13)21-22(29-16-7-5-15(11-16)24(29)28-21)14-6-8-19-18(12-14)17(23(25)30)9-10-26-19/h2-4,6,8-10,12,15-16H,5,7,11H2,1H3,(H2,25,30)/t15-,16+/m1/s1 CSMOUVFWIWCQLV-CVEARBPZSA-N 481147 6-((5S,8R)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)quinoline-4-carboxamide 1-1::US10906905, Example 1-1 TGF-beta receptor type-1 Human 9.00 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481147&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439679 443550322 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998156 Cc1cccc(n1)-c1nc2[C@H]3CC[C@H](C3)n2c1-c1ccc2nccc(C(N)=O)c2c1 InChI=1S/C24H21N5O/c1-13-3-2-4-20(27-13)21-22(29-16-7-5-15(11-16)24(29)28-21)14-6-8-19-18(12-14)17(23(25)30)9-10-26-19/h2-4,6,8-10,12,15-16H,5,7,11H2,1H3,(H2,25,30)/t15-,16+/m0/s1 CSMOUVFWIWCQLV-JKSUJKDBSA-N 481148 6-((5R,8S)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)quinoline-4-carboxamide 1-2::US10906905, Example 1-2 TGF-beta receptor type-1 Human 16.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481148&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439680 443550323 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998157 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccc2nnc(C(N)=O)n2c1 InChI=1S/C21H19N7O/c1-11-3-2-4-15(23-11)17-18(28-14-7-5-12(9-14)20(28)24-17)13-6-8-16-25-26-21(19(22)29)27(16)10-13/h2-4,6,8,10,12,14H,5,7,9H2,1H3,(H2,22,29)/t12-,14+/m1/s1 BKVNNKVIKPHFKN-OCCSQVGLSA-N 481161 6-((5S,8R)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)[1,2,4]triazolo[4,3-a]pyridine-3-carboxamide 2-1::US10906905, Example 2-1 TGF-beta receptor type-1 Human 3.00 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481161&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439677 443550336 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998158 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)S(C)(=O)=O InChI=1S/C26H24N4O2S/c1-16-4-3-5-22(28-16)24-25(30-20-9-6-19(14-20)26(30)29-24)18-12-13-27-23(15-18)17-7-10-21(11-8-17)33(2,31)32/h3-5,7-8,10-13,15,19-20H,6,9,14H2,1-2H3/t19-,20+/m1/s1 UARGTFDABIYTIP-UXHICEINSA-N 481162 (5S,8R)-2-(6-Methylpyridin-2-yl)-3-(2-(4-(methylsulfonyl)phenyl)pyridin-4-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 3-1::US10906905, Example 3-1 TGF-beta receptor type-1 Human 4.00 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481162&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439648 443550337 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998159 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(c1)-c1ccc(cc1)C(N)=O InChI=1S/C26H23N5O/c1-15-3-2-4-21(29-15)23-24(31-20-10-9-19(13-20)26(31)30-23)18-11-12-28-22(14-18)16-5-7-17(8-6-16)25(27)32/h2-8,11-12,14,19-20H,9-10,13H2,1H3,(H2,27,32) DOBRZXIRNFXQCN-UHFFFAOYSA-N 481163 4-(4-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)benzamide 4::US10906905, Example 4 TGF-beta receptor type-1 Human 29.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481163&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439647 443550338 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998160 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)C(N)=O InChI=1S/C26H23N5O/c1-15-3-2-4-21(29-15)23-24(31-20-10-9-19(13-20)26(31)30-23)18-11-12-28-22(14-18)16-5-7-17(8-6-16)25(27)32/h2-8,11-12,14,19-20H,9-10,13H2,1H3,(H2,27,32)/t19-,20+/m1/s1 DOBRZXIRNFXQCN-UXHICEINSA-N 481164 US10906905, Example 4-1 TGF-beta receptor type-1 Human 2.00 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481164&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439734 443550339 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998161 Cc1cccc(n1)-c1nc2[C@H]3CC[C@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)C(N)=O InChI=1S/C26H23N5O/c1-15-3-2-4-21(29-15)23-24(31-20-10-9-19(13-20)26(31)30-23)18-11-12-28-22(14-18)16-5-7-17(8-6-16)25(27)32/h2-8,11-12,14,19-20H,9-10,13H2,1H3,(H2,27,32)/t19-,20+/m0/s1 DOBRZXIRNFXQCN-VQTJNVASSA-N 481165 US10906905, Example 4-2 TGF-beta receptor type-1 Human 18.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481165&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439729 443550340 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998162 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccnc(NCCO)c1 InChI=1S/C21H23N5O/c1-13-3-2-4-17(24-13)19-20(14-7-8-22-18(12-14)23-9-10-27)26-16-6-5-15(11-16)21(26)25-19/h2-4,7-8,12,15-16,27H,5-6,9-11H2,1H3,(H,22,23)/t15-,16+/m1/s1 WGVBWEFONZDSBW-CVEARBPZSA-N 481166 2-((4-((5S,8R)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)amino)ethanol 5-1::US10906905, Example 5-1 TGF-beta receptor type-1 Human 46.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481166&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439728 443550341 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998163 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccc2nccnc2c1 InChI=1S/C22H19N5/c1-13-3-2-4-18(25-13)20-21(27-16-7-5-15(11-16)22(27)26-20)14-6-8-17-19(12-14)24-10-9-23-17/h2-4,6,8-10,12,15-16H,5,7,11H2,1H3 WKOVMPFJSORYMW-UHFFFAOYSA-N 481167 2-(6-Methylpyridin-2-yl)-3-(quinoxalin-6-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 6::US10906905, Example 6 TGF-beta receptor type-1 Human 26.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481167&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439567 443550342 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998164 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccc2nccnc2c1 InChI=1S/C22H19N5/c1-13-3-2-4-18(25-13)20-21(27-16-7-5-15(11-16)22(27)26-20)14-6-8-17-19(12-14)24-10-9-23-17/h2-4,6,8-10,12,15-16H,5,7,11H2,1H3/t15-,16+/m1/s1 WKOVMPFJSORYMW-CVEARBPZSA-N 481168 US10906905, Example 6-1 TGF-beta receptor type-1 Human 7.00 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481168&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439732 443550343 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998165 Cc1cccc(n1)-c1nc2[C@H]3CC[C@H](C3)n2c1-c1ccc2nccnc2c1 InChI=1S/C22H19N5/c1-13-3-2-4-18(25-13)20-21(27-16-7-5-15(11-16)22(27)26-20)14-6-8-17-19(12-14)24-10-9-23-17/h2-4,6,8-10,12,15-16H,5,7,11H2,1H3/t15-,16+/m0/s1 WKOVMPFJSORYMW-JKSUJKDBSA-N 481169 US10906905, Example 6-2 TGF-beta receptor type-1 Human 8.00 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481169&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439731 443550344 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998166 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccc2ncc(OCCO)nc2c1 InChI=1S/C24H23N5O2/c1-14-3-2-4-19(26-14)22-23(29-17-7-5-16(11-17)24(29)28-22)15-6-8-18-20(12-15)27-21(13-25-18)31-10-9-30/h2-4,6,8,12-13,16-17,30H,5,7,9-11H2,1H3 ZIDVIPHDKCJQPJ-UHFFFAOYSA-N 481170 2-((7-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)quinoxalin-2-yl)oxy)ethanol 7::US10906905, Example 7 TGF-beta receptor type-1 Human 20.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481170&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439804 443550345 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998167 NC(=O)c1nnc2ccc(cn12)-c1c(nc2C3CCC(C3)n12)-c1ccc(F)cn1 InChI=1S/C20H16FN7O/c21-12-3-5-14(23-8-12)16-17(28-13-4-1-10(7-13)19(28)24-16)11-2-6-15-25-26-20(18(22)29)27(15)9-11/h2-3,5-6,8-10,13H,1,4,7H2,(H2,22,29) KZNQXFBFJRDXTF-UHFFFAOYSA-N 481171 6-(2-(5-Fluoropyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine-3-carboxamide 9::US10906905, Example 9 TGF-beta receptor type-1 Human 43.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481171&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439581 443550346 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998168 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1cc2cnccc2s1 InChI=1S/C21H18N4S/c1-12-3-2-4-16(23-12)19-20(18-10-14-11-22-8-7-17(14)26-18)25-15-6-5-13(9-15)21(25)24-19/h2-4,7-8,10-11,13,15H,5-6,9H2,1H3 RRSBIRUCCSICSI-UHFFFAOYSA-N 481172 2-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl) thieno[3,2-c]pyridine 10::US10906905, Example 10 TGF-beta receptor type-1 Human 25.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481172&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439652 443550347 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998169 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccc2ncnn2c1 InChI=1S/C20H18N6/c1-12-3-2-4-16(23-12)18-19(14-6-8-17-21-11-22-25(17)10-14)26-15-7-5-13(9-15)20(26)24-18/h2-4,6,8,10-11,13,15H,5,7,9H2,1H3 JQUKBPVZXCMCRC-UHFFFAOYSA-N 481173 3-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-2-(6-methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 11::US10906905, Example 11 TGF-beta receptor type-1 Human 16.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481173&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439743 443550348 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998170 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(c1)-c1cnn(C)c1 InChI=1S/C23H22N6/c1-14-4-3-5-19(26-14)21-22(29-18-7-6-16(10-18)23(29)27-21)15-8-9-24-20(11-15)17-12-25-28(2)13-17/h3-5,8-9,11-13,16,18H,6-7,10H2,1-2H3 BPRNIBFKCRFPOU-UHFFFAOYSA-N 481174 3-(2-(1-Methyl-1H-pyrazol-4-yl)pyridin-4-yl)-2-(6-methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 12::US10906905, Example 12 TGF-beta receptor type-1 Human 9.00 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481174&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439695 443550349 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998171 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)S(N)(=O)=O InChI=1S/C25H23N5O2S/c1-15-3-2-4-21(28-15)23-24(30-19-8-5-18(13-19)25(30)29-23)17-11-12-27-22(14-17)16-6-9-20(10-7-16)33(26,31)32/h2-4,6-7,9-12,14,18-19H,5,8,13H2,1H3,(H2,26,31,32)/t18-,19+/m1/s1 KCDUOUDRTGBUCA-MOPGFXCFSA-N 481175 4-(4-((5S,8R)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)benzenesulfonamide 13-1::US10906905, Example 13-1 TGF-beta receptor type-1 Human 11.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481175&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439754 443550350 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998172 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(Nc2ccc(cc2)S(N)(=O)=O)c1 InChI=1S/C25H24N6O2S/c1-15-3-2-4-21(28-15)23-24(31-19-8-5-17(13-19)25(31)30-23)16-11-12-27-22(14-16)29-18-6-9-20(10-7-18)34(26,32)33/h2-4,6-7,9-12,14,17,19H,5,8,13H2,1H3,(H,27,29)(H2,26,32,33) MJWOMIHVCXLYLG-UHFFFAOYSA-N 481176 4-((4-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)amino)benzenesulfonamide 14::US10906905, Example 14 TGF-beta receptor type-1 Human 31.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481176&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439611 443550351 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998173 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccc2nccc(OC3CCNCC3)c2c1 InChI=1S/C28H29N5O/c1-17-3-2-4-24(31-17)26-27(33-20-7-5-19(15-20)28(33)32-26)18-6-8-23-22(16-18)25(11-14-30-23)34-21-9-12-29-13-10-21/h2-4,6,8,11,14,16,19-21,29H,5,7,9-10,12-13,15H2,1H3 KEMSCOAMTIJEOI-UHFFFAOYSA-N 481177 2-(6-Methylpyridin-2-yl)-3-(4-(piperidin-4-yloxy)quinolin-6-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 15::US10906905, Example 15 TGF-beta receptor type-1 Human 60.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481177&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439649 443550352 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998174 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccnc(NCCN2CCOCC2)c1 InChI=1S/C25H30N6O/c1-17-3-2-4-21(28-17)23-24(31-20-6-5-19(15-20)25(31)29-23)18-7-8-26-22(16-18)27-9-10-30-11-13-32-14-12-30/h2-4,7-8,16,19-20H,5-6,9-15H2,1H3,(H,26,27)/t19-,20+/m1/s1 ZZXGDBBWYFJMSC-UXHICEINSA-N 481178 4-((5S,8R)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)-N-(2-morpholinoethyl)pyridin-2-amine 16-1::US10906905, Example 16-1 TGF-beta receptor type-1 Human 77.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481178&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439871 443550353 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998175 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(c1)-c1ccc(cc1)C(=O)NC1CCOCC1 InChI=1S/C31H31N5O2/c1-19-3-2-4-26(33-19)28-29(36-25-10-9-23(17-25)30(36)35-28)22-11-14-32-27(18-22)20-5-7-21(8-6-20)31(37)34-24-12-15-38-16-13-24/h2-8,11,14,18,23-25H,9-10,12-13,15-17H2,1H3,(H,34,37) QRINOTMCPQYUCC-UHFFFAOYSA-N 481179 4-(4-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide 17::US10906905, Example 17 TGF-beta receptor type-1 Human 38.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481179&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439577 443550354 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998176 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)C(=O)NC1CCOCC1 InChI=1S/C31H31N5O2/c1-19-3-2-4-26(33-19)28-29(36-25-10-9-23(17-25)30(36)35-28)22-11-14-32-27(18-22)20-5-7-21(8-6-20)31(37)34-24-12-15-38-16-13-24/h2-8,11,14,18,23-25H,9-10,12-13,15-17H2,1H3,(H,34,37)/t23-,25+/m1/s1 QRINOTMCPQYUCC-NOZRDPDXSA-N 481180 US10906905, Example 17-1 TGF-beta receptor type-1 Human 28.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481180&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439584 443550355 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998177 Cc1cccc(n1)-c1nc2[C@H]3CC[C@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)C(=O)NC1CCOCC1 InChI=1S/C31H31N5O2/c1-19-3-2-4-26(33-19)28-29(36-25-10-9-23(17-25)30(36)35-28)22-11-14-32-27(18-22)20-5-7-21(8-6-20)31(37)34-24-12-15-38-16-13-24/h2-8,11,14,18,23-25H,9-10,12-13,15-17H2,1H3,(H,34,37)/t23-,25+/m0/s1 QRINOTMCPQYUCC-UKILVPOCSA-N 481181 US10906905, Example 17-2 TGF-beta receptor type-1 Human 28.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481181&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439590 443550356 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998178 C[C@H](O)CNc1cc(ccn1)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1cccc(C)n1 InChI=1S/C22H25N5O/c1-13-4-3-5-18(25-13)20-21(27-17-7-6-16(10-17)22(27)26-20)15-8-9-23-19(11-15)24-12-14(2)28/h3-5,8-9,11,14,16-17,28H,6-7,10,12H2,1-2H3,(H,23,24)/t14-,16+,17-/m0/s1 OJVIHUXKKQTTQR-UAGQMJEPSA-N 481182 (S)-1-((4-((5S,8R)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)amino)propan-2-ol 18-1::US10906905, Example 18-1 TGF-beta receptor type-1 Human 80.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481182&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439579 443550357 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998179 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(NCCO)c1 InChI=1S/C21H23N5O/c1-13-3-2-4-17(24-13)19-20(14-7-8-22-18(12-14)23-9-10-27)26-16-6-5-15(11-16)21(26)25-19/h2-4,7-8,12,15-16,27H,5-6,9-11H2,1H3,(H,22,23) WGVBWEFONZDSBW-UHFFFAOYSA-N 481183 2-((4-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)amino)ethanol 5::US10906905, Example 5 TGF-beta receptor type-1 Human 59.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481183&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439727 443550358 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998180 COC(=O)c1ccc(cc1)-c1cc(ccn1)-c1c(nc2C3CCC(C3)n12)-c1cccc(C)n1 InChI=1S/C27H24N4O2/c1-16-4-3-5-22(29-16)24-25(31-21-11-10-20(14-21)26(31)30-24)19-12-13-28-23(15-19)17-6-8-18(9-7-17)27(32)33-2/h3-9,12-13,15,20-21H,10-11,14H2,1-2H3 OFSNALMJHLIAKY-UHFFFAOYSA-N 481184 4-(4-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)benzoic acid 19::US10906905, Example 19 TGF-beta receptor type-1 Human 87.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481184&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439596 443550359 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998181 NC(=O)c1nnc2ccc(cn12)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C20H16FN7O/c21-12-3-5-14(23-8-12)16-17(28-13-4-1-10(7-13)19(28)24-16)11-2-6-15-25-26-20(18(22)29)27(15)9-11/h2-3,5-6,8-10,13H,1,4,7H2,(H2,22,29)/t10-,13+/m1/s1 KZNQXFBFJRDXTF-MFKMUULPSA-N 481185 US10906905, Example 9-1 TGF-beta receptor type-1 Human 13.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481185&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439745 443550360 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998182 NC(=O)c1nnc2ccc(cn12)-c1c(nc2[C@H]3CC[C@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C20H16FN7O/c21-12-3-5-14(23-8-12)16-17(28-13-4-1-10(7-13)19(28)24-16)11-2-6-15-25-26-20(18(22)29)27(15)9-11/h2-3,5-6,8-10,13H,1,4,7H2,(H2,22,29)/t10-,13+/m0/s1 KZNQXFBFJRDXTF-GXFFZTMASA-N 481186 US10906905, Example 9-2 TGF-beta receptor type-1 Human 13.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481186&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439740 443550361 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998183 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc2ccc(cc12)C(N)=O InChI=1S/C24H21N5O/c1-13-3-2-4-20(27-13)21-22(29-16-7-5-15(11-16)24(29)28-21)17-9-10-26-19-8-6-14(23(25)30)12-18(17)19/h2-4,6,8-10,12,15-16H,5,7,11H2,1H3,(H2,25,30) AXCVFCXJQCYEBU-UHFFFAOYSA-N 481187 4-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl) quinoline-6-carboxamide 29::US10906905, Example 29 TGF-beta receptor type-1 Human 85.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481187&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439670 443550362 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998184 Cc1cccc(n1)-c1nc2[C@H]3CC[C@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)S(C)(=O)=O InChI=1S/C26H24N4O2S/c1-16-4-3-5-22(28-16)24-25(30-20-9-6-19(14-20)26(30)29-24)18-12-13-27-23(15-18)17-7-10-21(11-8-17)33(2,31)32/h3-5,7-8,10-13,15,19-20H,6,9,14H2,1-2H3/t19-,20+/m0/s1 UARGTFDABIYTIP-VQTJNVASSA-N 481188 (5R,8S)-2-(6-Methylpyridin-2-yl)-3-(2-(4-(methylsulfonyl)phenyl)pyridin-4-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 3-2::US10906905, Example 3-2 TGF-beta receptor type-1 Human 23.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481188&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439681 443550363 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998185 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccc2nccc(C(N)=O)c2c1 InChI=1S/C24H21N5O/c1-13-3-2-4-20(27-13)21-22(29-16-7-5-15(11-16)24(29)28-21)14-6-8-19-18(12-14)17(23(25)30)9-10-26-19/h2-4,6,8-10,12,15-16H,5,7,11H2,1H3,(H2,25,30) CSMOUVFWIWCQLV-UHFFFAOYSA-N 481189 6-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl) quinoline-4-carboxamide 1::US10906905, Example 1 TGF-beta receptor type-1 Human 14.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481189&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439678 443550364 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998186 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(NC(=O)OC(C)(C)C)c1 InChI=1S/C24H27N5O2/c1-14-6-5-7-18(26-14)20-21(29-17-9-8-16(12-17)22(29)28-20)15-10-11-25-19(13-15)27-23(30)31-24(2,3)4/h5-7,10-11,13,16-17H,8-9,12H2,1-4H3,(H,25,27,30) XJGLUHVKZFPGAN-UHFFFAOYSA-N 481190 Tert-butyl (4-(2-(6-methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)carbamate 31::US10906905, Example 31 TGF-beta receptor type-1 Human 55.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481190&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439564 443550365 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998187 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(N)c1 InChI=1S/C19H19N5/c1-11-3-2-4-15(22-11)17-18(12-7-8-21-16(20)10-12)24-14-6-5-13(9-14)19(24)23-17/h2-4,7-8,10,13-14H,5-6,9H2,1H3,(H2,20,21) XLIFVQWVUKTORJ-UHFFFAOYSA-N 481191 4-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-amine 32::US10906905, Example 32 TGF-beta receptor type-1 Human 9.00 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481191&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439563 443550366 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998188 Cc1cccc(n1)-c1nn2C3CCC(CC3)c2c1-c1ccnc(c1)-c1ccc(cc1)S(C)(=O)=O InChI=1S/C27H26N4O2S/c1-17-4-3-5-23(29-17)26-25(27-19-6-10-21(11-7-19)31(27)30-26)20-14-15-28-24(16-20)18-8-12-22(13-9-18)34(2,32)33/h3-5,8-9,12-16,19,21H,6-7,10-11H2,1-2H3 NXDCVJJDDFFEON-UHFFFAOYSA-N 481192 2-(6-Methylpyridin-2-yl)-3-(2-(4-(methylsulfonyl)phenyl)pyridin-4-yl)-4,5,6,7-tetrahydro-4,7-ethanopyrazolo[1,5-a]pyridine 33::US10906905, Example 33 TGF-beta receptor type-1 Human 34.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481192&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439619 443550367 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998189 Cc1cccc(n1)-c1nn2C3CCC(CC3)c2c1-c1ccnc2ccc(cc12)C(N)=O InChI=1S/C25H23N5O/c1-14-3-2-4-21(28-14)23-22(24-15-5-8-17(9-6-15)30(24)29-23)18-11-12-27-20-10-7-16(25(26)31)13-19(18)20/h2-4,7,10-13,15,17H,5-6,8-9H2,1H3,(H2,26,31) WXDFWGNBHNFNIF-UHFFFAOYSA-N 481193 4-(2-(6-Methylpyridin-2-yl)-4,5,6,7-tetrahydro-4,7-ethanopyrazolo[1,5-a]pyridin-3-yl)quinoline-6-carboxamide 34::US10906905, Example 34 TGF-beta receptor type-1 Human 12.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481193&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439609 443550368 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998190 Cc1cccc(n1)-c1nn2C3CCC(C3)c2c1-c1ccnc2ccc(cc12)C(N)=O InChI=1S/C24H21N5O/c1-13-3-2-4-20(27-13)22-21(23-14-5-7-16(11-14)29(23)28-22)17-9-10-26-19-8-6-15(24(25)30)12-18(17)19/h2-4,6,8-10,12,14,16H,5,7,11H2,1H3,(H2,25,30) HPBBGUGOYYVTHJ-UHFFFAOYSA-N 481194 4-(2-(6-Methylpyridin-2-yl)-4,5,6,7-tetrahydro-4,7-methanopyrazolo[1,5-a]pyridin-3-yl)quinoline-6-carboxamide 35::US10906905, Example 35 TGF-beta receptor type-1 Human 12.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481194&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439624 443550369 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998191 Cc1cccc(n1)-c1nn2[C@@H]3CC[C@@H](C3)c2c1-c1ccnc2ccc(cc12)C(N)=O InChI=1S/C24H21N5O/c1-13-3-2-4-20(27-13)22-21(23-14-5-7-16(11-14)29(23)28-22)17-9-10-26-19-8-6-15(24(25)30)12-18(17)19/h2-4,6,8-10,12,14,16H,5,7,11H2,1H3,(H2,25,30)/t14-,16+/m0/s1 HPBBGUGOYYVTHJ-GOEBONIOSA-N 481195 US10906905, Example 35-1 TGF-beta receptor type-1 Human 39.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481195&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439684 443550370 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998192 Cc1cccc(n1)-c1nn2[C@H]3CC[C@H](C3)c2c1-c1ccnc2ccc(cc12)C(N)=O InChI=1S/C24H21N5O/c1-13-3-2-4-20(27-13)22-21(23-14-5-7-16(11-14)29(23)28-22)17-9-10-26-19-8-6-15(24(25)30)12-18(17)19/h2-4,6,8-10,12,14,16H,5,7,11H2,1H3,(H2,25,30)/t14-,16+/m1/s1 HPBBGUGOYYVTHJ-ZBFHGGJFSA-N 481196 US10906905, Example 35-2 TGF-beta receptor type-1 Human 25.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481196&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439683 443550371 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998193 Cc1cccc(n1)-c1nn2C3CCC(CC3)c2c1-c1ccc2nccc(C(N)=O)c2c1 InChI=1S/C25H23N5O/c1-14-3-2-4-21(28-14)23-22(24-15-5-8-17(9-6-15)30(24)29-23)16-7-10-20-19(13-16)18(25(26)31)11-12-27-20/h2-4,7,10-13,15,17H,5-6,8-9H2,1H3,(H2,26,31) NKEPPANSOKDJCW-UHFFFAOYSA-N 481197 6-(2-(6-Methylpyridin-2-yl)-4,5,6,7-tetrahydro-4,7-ethanopyrazolo[1,5-a]pyridin-3-yl)quinoline-4-carboxamide 36::US10906905, Example 36 TGF-beta receptor type-1 Human 21.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481197&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439601 443550372 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998194 Cc1cccc(n1)C1=NC2C3CCC(CC3)[N]2=C1c1ccnc(NCCO)c1 InChI=1S/C22H26N5O/c1-14-3-2-4-18(25-14)20-21(16-9-10-23-19(13-16)24-11-12-28)27-17-7-5-15(6-8-17)22(27)26-20/h2-4,9-10,13,15,17,22,28H,5-8,11-12H2,1H3,(H,23,24) FEQSOIGIXDCRPU-UHFFFAOYSA-N 481198 2-((4-(2-(6-Methylpyridin-2-yl)-4,5,6,7-tetrahydro-4,7-ethanopyrazolo[1,5-a]pyridin-3-yl)pyridin-2-yl)amino)ethanol 37::US10906905, Example 37 TGF-beta receptor type-1 Human 52.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481198&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 147486371 443550373 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998195 Cc1cccc(n1)-c1nn2C3CCC(CC3)c2c1-c1ccc2ncnn2c1 InChI=1S/C21H20N6/c1-13-3-2-4-17(24-13)20-19(15-7-10-18-22-12-23-26(18)11-15)21-14-5-8-16(9-6-14)27(21)25-20/h2-4,7,10-12,14,16H,5-6,8-9H2,1H3 CKUFSCILDUIBGC-UHFFFAOYSA-N 481199 3-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-2-(6-methylpyridin-2-yl)-4,5,6,7-tetrahydro-4,7-ethanopyrazolo[1,5-a]pyridine 38::US10906905, Example 38 TGF-beta receptor type-1 Human 9.00 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481199&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439630 443550374 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998196 NC(=O)c1ccnc2ccc(cc12)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C23H18FN5O/c24-14-3-6-19(27-11-14)20-21(29-15-4-1-13(9-15)23(29)28-20)12-2-5-18-17(10-12)16(22(25)30)7-8-26-18/h2-3,5-8,10-11,13,15H,1,4,9H2,(H2,25,30)/t13-,15+/m1/s1 IMNHEZQIZVJYRU-HIFRSBDPSA-N 481200 6-((5S,8R)-2-(5-Fluoropyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyrid in-3-yl)quinoline-4-carboxamide 39-1::US10906905, Example 39-1 TGF-beta receptor type-1 Human 26.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481200&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439632 443550375 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998197 Cn1cc(cn1)-c1cc(ccn1)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C22H19FN6/c1-28-12-15(10-26-28)19-9-13(6-7-24-19)21-20(18-5-3-16(23)11-25-18)27-22-14-2-4-17(8-14)29(21)22/h3,5-7,9-12,14,17H,2,4,8H2,1H3/t14-,17+/m1/s1 OKJBNDABXTVZHD-PBHICJAKSA-N 481201 (5S,8R)-2-(5-Fluoropyridin-2-yl)-3-(2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 40-1::US10906905, Example 40-1 TGF-beta receptor type-1 Human 10.00 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481201&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439636 443550376 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998198 NC(=O)c1ccc(cc1)-c1cc(ccn1)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C25H20FN5O/c26-18-6-8-20(29-13-18)22-23(31-19-7-5-17(11-19)25(31)30-22)16-9-10-28-21(12-16)14-1-3-15(4-2-14)24(27)32/h1-4,6,8-10,12-13,17,19H,5,7,11H2,(H2,27,32)/t17-,19+/m1/s1 IGWPJSQVBRPANZ-MJGOQNOKSA-N 481202 4-(4-((5S,8R)-2-(5-Fluoropyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)benzamide 41-1::US10906905, Example 41-1 TGF-beta receptor type-1 Human 28.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481202&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439635 443550377 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998199 Cc1cccc(n1)-c1nc2[C@H]3CC[C@H](C3)n2c1-c1ccc2nnc(C(N)=O)n2c1 InChI=1S/C21H19N7O/c1-11-3-2-4-15(23-11)17-18(28-14-7-5-12(9-14)20(28)24-17)13-6-8-16-25-26-21(19(22)29)27(16)10-13/h2-4,6,8,10,12,14H,5,7,9H2,1H3,(H2,22,29)/t12-,14+/m0/s1 BKVNNKVIKPHFKN-GXTWGEPZSA-N 481203 6-((5R,8S)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)[1,2,4]triazolo[4,3-a]pyridine-3-carboxamide 2-2::US10906905, Example 2-2 TGF-beta receptor type-1 Human 3.00 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481203&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439593 443550378 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998200 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(c1)-c1cnn(c1)S(C)(=O)=O InChI=1S/C23H22N6O2S/c1-14-4-3-5-19(26-14)21-22(29-18-7-6-16(10-18)23(29)27-21)15-8-9-24-20(11-15)17-12-25-28(13-17)32(2,30)31/h3-5,8-9,11-13,16,18H,6-7,10H2,1-2H3 MMWRLDUOCZWADE-UHFFFAOYSA-N 481204 2-(6-Methylpyridin-2-yl)-3-(2-(1-(methylsulfonyl)-1H-pyrazol-4-yl)pyridin-4-yl)-5, 6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 43::US10906905, Example 43 TGF-beta receptor type-1 Human 21.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481204&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439756 443550379 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998201 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccnc(c1)-c1cnn(C)c1 InChI=1S/C23H22N6/c1-14-4-3-5-19(26-14)21-22(29-18-7-6-16(10-18)23(29)27-21)15-8-9-24-20(11-15)17-12-25-28(2)13-17/h3-5,8-9,11-13,16,18H,6-7,10H2,1-2H3/t16-,18+/m1/s1 BPRNIBFKCRFPOU-AEFFLSMTSA-N 481205 US10906905, Example 12-1 TGF-beta receptor type-1 Human 6.00 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481205&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439801 443550380 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998202 Cc1cccc(n1)-c1nc2[C@H]3CC[C@H](C3)n2c1-c1ccnc(c1)-c1cnn(C)c1 InChI=1S/C23H22N6/c1-14-4-3-5-19(26-14)21-22(29-18-7-6-16(10-18)23(29)27-21)15-8-9-24-20(11-15)17-12-25-28(2)13-17/h3-5,8-9,11-13,16,18H,6-7,10H2,1-2H3/t16-,18+/m0/s1 BPRNIBFKCRFPOU-FUHWJXTLSA-N 481206 US10906905, Example 12-2 TGF-beta receptor type-1 Human 7.00 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481206&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 139418909 443550381 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998203 NC(=O)c1ccnc2ccc(cc12)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccccn1 InChI=1S/C23H19N5O/c24-22(29)16-8-10-26-18-7-5-13(12-17(16)18)21-20(19-3-1-2-9-25-19)27-23-14-4-6-15(11-14)28(21)23/h1-3,5,7-10,12,14-15H,4,6,11H2,(H2,24,29)/t14-,15+/m1/s1 WJYMSSHTDGFYAA-CABCVRRESA-N 481207 6-((5S,8R)-2-(Pyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl) quinoline-4-carboxamide 45-1::US10906905, Example 45-1 TGF-beta receptor type-1 Human 29.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481207&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439748 443550382 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998204 CS(=O)(=O)c1ccc(cc1)-c1cc(ccn1)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccccn1 InChI=1S/C25H22N4O2S/c1-32(30,31)20-9-6-16(7-10-20)22-15-17(11-13-27-22)24-23(21-4-2-3-12-26-21)28-25-18-5-8-19(14-18)29(24)25/h2-4,6-7,9-13,15,18-19H,5,8,14H2,1H3/t18-,19+/m1/s1 ONAVWQJVYCBQLZ-MOPGFXCFSA-N 481208 (5S,8R)-3-(2-(4-(Methylsulfonyl)phenyl)pyridin-4-yl)-2-(pyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 46-1::US10906905, Example 46-1 TGF-beta receptor type-1 Human 34.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481208&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439712 443550383 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998205 NC(=O)c1nnc2cc(ccn12)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccccn1 InChI=1S/C20H17N7O/c21-18(28)20-25-24-15-10-11(6-8-26(15)20)17-16(14-3-1-2-7-22-14)23-19-12-4-5-13(9-12)27(17)19/h1-3,6-8,10,12-13H,4-5,9H2,(H2,21,28)/t12-,13+/m1/s1 LRRPGJFORFFSKO-OLZOCXBDSA-N 481209 7-((5S,8R)-2-(Pyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine-3-carboxamide 47-1::US10906905, Example 47-1 TGF-beta receptor type-1 Human 39.0 US Patent 10.7270/Q26Q21BC aid1805230 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=750&target=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481209&enzyme=TGF-beta+receptor+type-1&column=ki&startPg=0&Increment=50&submit=Search 134439866 443550384 1 MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 1IAS,1PY5,1RW8,1VJY,2WOT,2WOU,2X7O,3FAA,3GXL,3HMM,3KCF,3KFD,3TZM,4X0M,4X2F,4X2G,4X2J,4X2K,4X2N,5E8S,5E8T,5E8W,5E8Z,5FRI,5QIK,5QIL,5QIM,5QTZ,5QU0,5USQ,6B8Y,6MAC TGF-beta receptor type-1 TGFR1_HUMAN P36897 Q6IR47 Q706C0 Q706C1 998206 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccc2nccc(C(N)=O)c2c1 InChI=1S/C24H21N5O/c1-13-3-2-4-20(27-13)21-22(29-16-7-5-15(11-16)24(29)28-21)14-6-8-19-18(12-14)17(23(25)30)9-10-26-19/h2-4,6,8-10,12,15-16H,5,7,11H2,1H3,(H2,25,30)/t15-,16+/m1/s1 CSMOUVFWIWCQLV-CVEARBPZSA-N 481147 6-((5S,8R)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)quinoline-4-carboxamide 1-1::US10906905, Example 1-1 Vascular endothelial growth factor receptor 2 Homo sapiens 3048 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481147&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439679 443550322 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998207 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccc2nnc(C(N)=O)n2c1 InChI=1S/C21H19N7O/c1-11-3-2-4-15(23-11)17-18(28-14-7-5-12(9-14)20(28)24-17)13-6-8-16-25-26-21(19(22)29)27(16)10-13/h2-4,6,8,10,12,14H,5,7,9H2,1H3,(H2,22,29)/t12-,14+/m1/s1 BKVNNKVIKPHFKN-OCCSQVGLSA-N 481161 6-((5S,8R)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)[1,2,4]triazolo[4,3-a]pyridine-3-carboxamide 2-1::US10906905, Example 2-1 Vascular endothelial growth factor receptor 2 Homo sapiens 1156 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481161&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439677 443550336 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998208 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)S(C)(=O)=O InChI=1S/C26H24N4O2S/c1-16-4-3-5-22(28-16)24-25(30-20-9-6-19(14-20)26(30)29-24)18-12-13-27-23(15-18)17-7-10-21(11-8-17)33(2,31)32/h3-5,7-8,10-13,15,19-20H,6,9,14H2,1-2H3/t19-,20+/m1/s1 UARGTFDABIYTIP-UXHICEINSA-N 481162 (5S,8R)-2-(6-Methylpyridin-2-yl)-3-(2-(4-(methylsulfonyl)phenyl)pyridin-4-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 3-1::US10906905, Example 3-1 Vascular endothelial growth factor receptor 2 Homo sapiens 2890 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481162&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439648 443550337 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998209 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(c1)-c1ccc(cc1)C(N)=O InChI=1S/C26H23N5O/c1-15-3-2-4-21(29-15)23-24(31-20-10-9-19(13-20)26(31)30-23)18-11-12-28-22(14-18)16-5-7-17(8-6-16)25(27)32/h2-8,11-12,14,19-20H,9-10,13H2,1H3,(H2,27,32) DOBRZXIRNFXQCN-UHFFFAOYSA-N 481163 4-(4-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)benzamide 4::US10906905, Example 4 Vascular endothelial growth factor receptor 2 Homo sapiens 4055 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481163&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439647 443550338 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998210 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)C(N)=O InChI=1S/C26H23N5O/c1-15-3-2-4-21(29-15)23-24(31-20-10-9-19(13-20)26(31)30-23)18-11-12-28-22(14-18)16-5-7-17(8-6-16)25(27)32/h2-8,11-12,14,19-20H,9-10,13H2,1H3,(H2,27,32)/t19-,20+/m1/s1 DOBRZXIRNFXQCN-UXHICEINSA-N 481164 US10906905, Example 4-1 Vascular endothelial growth factor receptor 2 Homo sapiens 1052 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481164&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439734 443550339 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998211 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccnc(NCCO)c1 InChI=1S/C21H23N5O/c1-13-3-2-4-17(24-13)19-20(14-7-8-22-18(12-14)23-9-10-27)26-16-6-5-15(11-16)21(26)25-19/h2-4,7-8,12,15-16,27H,5-6,9-11H2,1H3,(H,22,23)/t15-,16+/m1/s1 WGVBWEFONZDSBW-CVEARBPZSA-N 481166 2-((4-((5S,8R)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)amino)ethanol 5-1::US10906905, Example 5-1 Vascular endothelial growth factor receptor 2 Homo sapiens 3709 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481166&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439728 443550341 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998212 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(Nc2ccc(cc2)S(N)(=O)=O)c1 InChI=1S/C25H24N6O2S/c1-15-3-2-4-21(28-15)23-24(31-19-8-5-17(13-19)25(31)30-23)16-11-12-27-22(14-16)29-18-6-9-20(10-7-18)34(26,32)33/h2-4,6-7,9-12,14,17,19H,5,8,13H2,1H3,(H,27,29)(H2,26,32,33) MJWOMIHVCXLYLG-UHFFFAOYSA-N 481176 4-((4-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)amino)benzenesulfonamide 14::US10906905, Example 14 Vascular endothelial growth factor receptor 2 Homo sapiens 1001 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481176&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439611 443550351 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998213 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccnc(NCCN2CCOCC2)c1 InChI=1S/C25H30N6O/c1-17-3-2-4-21(28-17)23-24(31-20-6-5-19(15-20)25(31)29-23)18-7-8-26-22(16-18)27-9-10-30-11-13-32-14-12-30/h2-4,7-8,16,19-20H,5-6,9-15H2,1H3,(H,26,27)/t19-,20+/m1/s1 ZZXGDBBWYFJMSC-UXHICEINSA-N 481178 4-((5S,8R)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)-N-(2-morpholinoethyl)pyridin-2-amine 16-1::US10906905, Example 16-1 Vascular endothelial growth factor receptor 2 Homo sapiens >10000 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481178&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439871 443550353 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998214 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(c1)-c1ccc(cc1)C(=O)NC1CCOCC1 InChI=1S/C31H31N5O2/c1-19-3-2-4-26(33-19)28-29(36-25-10-9-23(17-25)30(36)35-28)22-11-14-32-27(18-22)20-5-7-21(8-6-20)31(37)34-24-12-15-38-16-13-24/h2-8,11,14,18,23-25H,9-10,12-13,15-17H2,1H3,(H,34,37) QRINOTMCPQYUCC-UHFFFAOYSA-N 481179 4-(4-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide 17::US10906905, Example 17 Vascular endothelial growth factor receptor 2 Homo sapiens 919 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481179&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439577 443550354 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998215 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)C(=O)NC1CCOCC1 InChI=1S/C31H31N5O2/c1-19-3-2-4-26(33-19)28-29(36-25-10-9-23(17-25)30(36)35-28)22-11-14-32-27(18-22)20-5-7-21(8-6-20)31(37)34-24-12-15-38-16-13-24/h2-8,11,14,18,23-25H,9-10,12-13,15-17H2,1H3,(H,34,37)/t23-,25+/m1/s1 QRINOTMCPQYUCC-NOZRDPDXSA-N 481180 US10906905, Example 17-1 Vascular endothelial growth factor receptor 2 Homo sapiens 871 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481180&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439584 443550355 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998216 Cc1cccc(n1)-c1nc2[C@H]3CC[C@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)C(=O)NC1CCOCC1 InChI=1S/C31H31N5O2/c1-19-3-2-4-26(33-19)28-29(36-25-10-9-23(17-25)30(36)35-28)22-11-14-32-27(18-22)20-5-7-21(8-6-20)31(37)34-24-12-15-38-16-13-24/h2-8,11,14,18,23-25H,9-10,12-13,15-17H2,1H3,(H,34,37)/t23-,25+/m0/s1 QRINOTMCPQYUCC-UKILVPOCSA-N 481181 US10906905, Example 17-2 Vascular endothelial growth factor receptor 2 Homo sapiens 960 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481181&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439590 443550356 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998217 NC(=O)c1nnc2ccc(cn12)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C20H16FN7O/c21-12-3-5-14(23-8-12)16-17(28-13-4-1-10(7-13)19(28)24-16)11-2-6-15-25-26-20(18(22)29)27(15)9-11/h2-3,5-6,8-10,13H,1,4,7H2,(H2,22,29)/t10-,13+/m1/s1 KZNQXFBFJRDXTF-MFKMUULPSA-N 481185 US10906905, Example 9-1 Vascular endothelial growth factor receptor 2 Homo sapiens >10000 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481185&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439745 443550360 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998218 NC(=O)c1nnc2ccc(cn12)-c1c(nc2[C@H]3CC[C@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C20H16FN7O/c21-12-3-5-14(23-8-12)16-17(28-13-4-1-10(7-13)19(28)24-16)11-2-6-15-25-26-20(18(22)29)27(15)9-11/h2-3,5-6,8-10,13H,1,4,7H2,(H2,22,29)/t10-,13+/m0/s1 KZNQXFBFJRDXTF-GXFFZTMASA-N 481186 US10906905, Example 9-2 Vascular endothelial growth factor receptor 2 Homo sapiens 1346 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481186&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439740 443550361 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998219 Cc1cccc(n1)-c1nc2[C@H]3CC[C@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)S(C)(=O)=O InChI=1S/C26H24N4O2S/c1-16-4-3-5-22(28-16)24-25(30-20-9-6-19(14-20)26(30)29-24)18-12-13-27-23(15-18)17-7-10-21(11-8-17)33(2,31)32/h3-5,7-8,10-13,15,19-20H,6,9,14H2,1-2H3/t19-,20+/m0/s1 UARGTFDABIYTIP-VQTJNVASSA-N 481188 (5R,8S)-2-(6-Methylpyridin-2-yl)-3-(2-(4-(methylsulfonyl)phenyl)pyridin-4-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 3-2::US10906905, Example 3-2 Vascular endothelial growth factor receptor 2 Homo sapiens 928 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481188&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439681 443550363 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998220 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(N)c1 InChI=1S/C19H19N5/c1-11-3-2-4-15(22-11)17-18(12-7-8-21-16(20)10-12)24-14-6-5-13(9-14)19(24)23-17/h2-4,7-8,10,13-14H,5-6,9H2,1H3,(H2,20,21) XLIFVQWVUKTORJ-UHFFFAOYSA-N 481191 4-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-amine 32::US10906905, Example 32 Vascular endothelial growth factor receptor 2 Homo sapiens 1122 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481191&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439563 443550366 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998221 Cc1cccc(n1)-c1nn2C3CCC(CC3)c2c1-c1ccnc2ccc(cc12)C(N)=O InChI=1S/C25H23N5O/c1-14-3-2-4-21(28-14)23-22(24-15-5-8-17(9-6-15)30(24)29-23)18-11-12-27-20-10-7-16(25(26)31)13-19(18)20/h2-4,7,10-13,15,17H,5-6,8-9H2,1H3,(H2,26,31) WXDFWGNBHNFNIF-UHFFFAOYSA-N 481193 4-(2-(6-Methylpyridin-2-yl)-4,5,6,7-tetrahydro-4,7-ethanopyrazolo[1,5-a]pyridin-3-yl)quinoline-6-carboxamide 34::US10906905, Example 34 Vascular endothelial growth factor receptor 2 Homo sapiens 1243 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481193&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439609 443550368 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998222 Cc1cccc(n1)-c1nn2[C@@H]3CC[C@@H](C3)c2c1-c1ccnc2ccc(cc12)C(N)=O InChI=1S/C24H21N5O/c1-13-3-2-4-20(27-13)22-21(23-14-5-7-16(11-14)29(23)28-22)17-9-10-26-19-8-6-15(24(25)30)12-18(17)19/h2-4,6,8-10,12,14,16H,5,7,11H2,1H3,(H2,25,30)/t14-,16+/m0/s1 HPBBGUGOYYVTHJ-GOEBONIOSA-N 481195 US10906905, Example 35-1 Vascular endothelial growth factor receptor 2 Homo sapiens 1711 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481195&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439684 443550370 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998223 Cc1cccc(n1)-c1nn2C3CCC(CC3)c2c1-c1ccc2nccc(C(N)=O)c2c1 InChI=1S/C25H23N5O/c1-14-3-2-4-21(28-14)23-22(24-15-5-8-17(9-6-15)30(24)29-23)16-7-10-20-19(13-16)18(25(26)31)11-12-27-20/h2-4,7,10-13,15,17H,5-6,8-9H2,1H3,(H2,26,31) NKEPPANSOKDJCW-UHFFFAOYSA-N 481197 6-(2-(6-Methylpyridin-2-yl)-4,5,6,7-tetrahydro-4,7-ethanopyrazolo[1,5-a]pyridin-3-yl)quinoline-4-carboxamide 36::US10906905, Example 36 Vascular endothelial growth factor receptor 2 Homo sapiens 1008 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481197&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439601 443550372 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998224 Cc1cccc(n1)C1=NC2C3CCC(CC3)[N]2=C1c1ccnc(NCCO)c1 InChI=1S/C22H26N5O/c1-14-3-2-4-18(25-14)20-21(16-9-10-23-19(13-16)24-11-12-28)27-17-7-5-15(6-8-17)22(27)26-20/h2-4,9-10,13,15,17,22,28H,5-8,11-12H2,1H3,(H,23,24) FEQSOIGIXDCRPU-UHFFFAOYSA-N 481198 2-((4-(2-(6-Methylpyridin-2-yl)-4,5,6,7-tetrahydro-4,7-ethanopyrazolo[1,5-a]pyridin-3-yl)pyridin-2-yl)amino)ethanol 37::US10906905, Example 37 Vascular endothelial growth factor receptor 2 Homo sapiens 2910 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481198&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 147486371 443550373 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998225 NC(=O)c1ccnc2ccc(cc12)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C23H18FN5O/c24-14-3-6-19(27-11-14)20-21(29-15-4-1-13(9-15)23(29)28-20)12-2-5-18-17(10-12)16(22(25)30)7-8-26-18/h2-3,5-8,10-11,13,15H,1,4,9H2,(H2,25,30)/t13-,15+/m1/s1 IMNHEZQIZVJYRU-HIFRSBDPSA-N 481200 6-((5S,8R)-2-(5-Fluoropyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyrid in-3-yl)quinoline-4-carboxamide 39-1::US10906905, Example 39-1 Vascular endothelial growth factor receptor 2 Homo sapiens 6305 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481200&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439632 443550375 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998226 Cn1cc(cn1)-c1cc(ccn1)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C22H19FN6/c1-28-12-15(10-26-28)19-9-13(6-7-24-19)21-20(18-5-3-16(23)11-25-18)27-22-14-2-4-17(8-14)29(21)22/h3,5-7,9-12,14,17H,2,4,8H2,1H3/t14-,17+/m1/s1 OKJBNDABXTVZHD-PBHICJAKSA-N 481201 (5S,8R)-2-(5-Fluoropyridin-2-yl)-3-(2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 40-1::US10906905, Example 40-1 Vascular endothelial growth factor receptor 2 Homo sapiens 2083 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481201&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439636 443550376 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998227 CS(=O)(=O)c1ccc(cc1)-c1cc(ccn1)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C25H21FN4O2S/c1-33(31,32)20-7-3-15(4-8-20)22-13-16(10-11-27-22)24-23(21-9-5-18(26)14-28-21)29-25-17-2-6-19(12-17)30(24)25/h3-5,7-11,13-14,17,19H,2,6,12H2,1H3/t17-,19+/m1/s1 QXSNTBHAJYMYMR-MJGOQNOKSA-N 481210 (5S,8R)-2-(5-Fluoropyridin-2-yl)-3-(2-(4-(methylsulfonyl)phenyl)pyridin-4-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 42-1::US10906905, Example 42-1 Vascular endothelial growth factor receptor 2 Homo sapiens 9736 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481210&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439704 443550385 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998228 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(c1)-c1cnn(c1)S(C)(=O)=O InChI=1S/C23H22N6O2S/c1-14-4-3-5-19(26-14)21-22(29-18-7-6-16(10-18)23(29)27-21)15-8-9-24-20(11-15)17-12-25-28(13-17)32(2,30)31/h3-5,8-9,11-13,16,18H,6-7,10H2,1-2H3 MMWRLDUOCZWADE-UHFFFAOYSA-N 481204 2-(6-Methylpyridin-2-yl)-3-(2-(1-(methylsulfonyl)-1H-pyrazol-4-yl)pyridin-4-yl)-5, 6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 43::US10906905, Example 43 Vascular endothelial growth factor receptor 2 Homo sapiens 551 US Patent 10.7270/Q26Q21BC aid1805231 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=692&target=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481204&enzyme=Vascular+endothelial+growth+factor+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134439756 443550379 1 MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV 1Y6A,1Y6B,3KVQ,3S35,3S36,3S37,3V2A,3VHE,3VID,5OYJ Vascular endothelial growth factor receptor 2 VGFR2_HUMAN P35968 A2RRS0 B5A925 C5IFA0 O60723 Q14178 998229 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccc2nccc(C(N)=O)c2c1 InChI=1S/C24H21N5O/c1-13-3-2-4-20(27-13)21-22(29-16-7-5-15(11-16)24(29)28-21)14-6-8-19-18(12-14)17(23(25)30)9-10-26-19/h2-4,6,8-10,12,15-16H,5,7,11H2,1H3,(H2,25,30)/t15-,16+/m1/s1 CSMOUVFWIWCQLV-CVEARBPZSA-N 481147 6-((5S,8R)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)quinoline-4-carboxamide 1-1::US10906905, Example 1-1 Mitogen-activated protein kinase 14 Homo sapiens 618 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481147&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439679 443550322 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 998230 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccc2nnc(C(N)=O)n2c1 InChI=1S/C21H19N7O/c1-11-3-2-4-15(23-11)17-18(28-14-7-5-12(9-14)20(28)24-17)13-6-8-16-25-26-21(19(22)29)27(16)10-13/h2-4,6,8,10,12,14H,5,7,9H2,1H3,(H2,22,29)/t12-,14+/m1/s1 BKVNNKVIKPHFKN-OCCSQVGLSA-N 481161 6-((5S,8R)-2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)[1,2,4]triazolo[4,3-a]pyridine-3-carboxamide 2-1::US10906905, Example 2-1 Mitogen-activated protein kinase 14 Homo sapiens 1710 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481161&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439677 443550336 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 998231 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)S(C)(=O)=O InChI=1S/C26H24N4O2S/c1-16-4-3-5-22(28-16)24-25(30-20-9-6-19(14-20)26(30)29-24)18-12-13-27-23(15-18)17-7-10-21(11-8-17)33(2,31)32/h3-5,7-8,10-13,15,19-20H,6,9,14H2,1-2H3/t19-,20+/m1/s1 UARGTFDABIYTIP-UXHICEINSA-N 481162 (5S,8R)-2-(6-Methylpyridin-2-yl)-3-(2-(4-(methylsulfonyl)phenyl)pyridin-4-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 3-1::US10906905, Example 3-1 Mitogen-activated protein kinase 14 Homo sapiens 686 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481162&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439648 443550337 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 998232 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(c1)-c1ccc(cc1)C(N)=O InChI=1S/C26H23N5O/c1-15-3-2-4-21(29-15)23-24(31-20-10-9-19(13-20)26(31)30-23)18-11-12-28-22(14-18)16-5-7-17(8-6-16)25(27)32/h2-8,11-12,14,19-20H,9-10,13H2,1H3,(H2,27,32) DOBRZXIRNFXQCN-UHFFFAOYSA-N 481163 4-(4-(2-(6-Methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridin-3-yl)pyridin-2-yl)benzamide 4::US10906905, Example 4 Mitogen-activated protein kinase 14 Homo sapiens 638 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481163&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439647 443550338 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 998233 Cc1cccc(n1)-c1nc2[C@@H]3CC[C@@H](C3)n2c1-c1ccc2nccnc2c1 InChI=1S/C22H19N5/c1-13-3-2-4-18(25-13)20-21(27-16-7-5-15(11-16)22(27)26-20)14-6-8-17-19(12-14)24-10-9-23-17/h2-4,6,8-10,12,15-16H,5,7,11H2,1H3/t15-,16+/m1/s1 WKOVMPFJSORYMW-CVEARBPZSA-N 481168 US10906905, Example 6-1 Mitogen-activated protein kinase 14 Homo sapiens 515 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481168&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439732 443550343 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 998234 Cc1cccc(n1)-c1nc2C3CCC(C3)n2c1-c1ccnc(c1)-c1cnn(C)c1 InChI=1S/C23H22N6/c1-14-4-3-5-19(26-14)21-22(29-18-7-6-16(10-18)23(29)27-21)15-8-9-24-20(11-15)17-12-25-28(2)13-17/h3-5,8-9,11-13,16,18H,6-7,10H2,1-2H3 BPRNIBFKCRFPOU-UHFFFAOYSA-N 481174 3-(2-(1-Methyl-1H-pyrazol-4-yl)pyridin-4-yl)-2-(6-methylpyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 12::US10906905, Example 12 Mitogen-activated protein kinase 14 Homo sapiens 454 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481174&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439695 443550349 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 998235 NC(=O)c1nnc2ccc(cn12)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C20H16FN7O/c21-12-3-5-14(23-8-12)16-17(28-13-4-1-10(7-13)19(28)24-16)11-2-6-15-25-26-20(18(22)29)27(15)9-11/h2-3,5-6,8-10,13H,1,4,7H2,(H2,22,29)/t10-,13+/m1/s1 KZNQXFBFJRDXTF-MFKMUULPSA-N 481185 US10906905, Example 9-1 Mitogen-activated protein kinase 14 Homo sapiens 5798 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481185&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439745 443550360 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 998236 NC(=O)c1nnc2ccc(cn12)-c1c(nc2[C@H]3CC[C@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C20H16FN7O/c21-12-3-5-14(23-8-12)16-17(28-13-4-1-10(7-13)19(28)24-16)11-2-6-15-25-26-20(18(22)29)27(15)9-11/h2-3,5-6,8-10,13H,1,4,7H2,(H2,22,29)/t10-,13+/m0/s1 KZNQXFBFJRDXTF-GXFFZTMASA-N 481186 US10906905, Example 9-2 Mitogen-activated protein kinase 14 Homo sapiens 2456 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481186&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439740 443550361 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 998237 Cc1cccc(n1)-c1nc2[C@H]3CC[C@H](C3)n2c1-c1ccnc(c1)-c1ccc(cc1)S(C)(=O)=O InChI=1S/C26H24N4O2S/c1-16-4-3-5-22(28-16)24-25(30-20-9-6-19(14-20)26(30)29-24)18-12-13-27-23(15-18)17-7-10-21(11-8-17)33(2,31)32/h3-5,7-8,10-13,15,19-20H,6,9,14H2,1-2H3/t19-,20+/m0/s1 UARGTFDABIYTIP-VQTJNVASSA-N 481188 (5R,8S)-2-(6-Methylpyridin-2-yl)-3-(2-(4-(methylsulfonyl)phenyl)pyridin-4-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 3-2::US10906905, Example 3-2 Mitogen-activated protein kinase 14 Homo sapiens 654 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481188&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439681 443550363 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 998238 Cc1cccc(n1)-c1nn2C3CCC(CC3)c2c1-c1ccnc(c1)-c1ccc(cc1)S(C)(=O)=O InChI=1S/C27H26N4O2S/c1-17-4-3-5-23(29-17)26-25(27-19-6-10-21(11-7-19)31(27)30-26)20-14-15-28-24(16-20)18-8-12-22(13-9-18)34(2,32)33/h3-5,8-9,12-16,19,21H,6-7,10-11H2,1-2H3 NXDCVJJDDFFEON-UHFFFAOYSA-N 481192 2-(6-Methylpyridin-2-yl)-3-(2-(4-(methylsulfonyl)phenyl)pyridin-4-yl)-4,5,6,7-tetrahydro-4,7-ethanopyrazolo[1,5-a]pyridine 33::US10906905, Example 33 Mitogen-activated protein kinase 14 Homo sapiens 563 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481192&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439619 443550367 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 998239 Cc1cccc(n1)-c1nn2C3CCC(CC3)c2c1-c1ccc2nccc(C(N)=O)c2c1 InChI=1S/C25H23N5O/c1-14-3-2-4-21(28-14)23-22(24-15-5-8-17(9-6-15)30(24)29-23)16-7-10-20-19(13-16)18(25(26)31)11-12-27-20/h2-4,7,10-13,15,17H,5-6,8-9H2,1H3,(H2,26,31) NKEPPANSOKDJCW-UHFFFAOYSA-N 481197 6-(2-(6-Methylpyridin-2-yl)-4,5,6,7-tetrahydro-4,7-ethanopyrazolo[1,5-a]pyridin-3-yl)quinoline-4-carboxamide 36::US10906905, Example 36 Mitogen-activated protein kinase 14 Homo sapiens 598 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481197&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439601 443550372 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 998240 NC(=O)c1ccnc2ccc(cc12)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C23H18FN5O/c24-14-3-6-19(27-11-14)20-21(29-15-4-1-13(9-15)23(29)28-20)12-2-5-18-17(10-12)16(22(25)30)7-8-26-18/h2-3,5-8,10-11,13,15H,1,4,9H2,(H2,25,30)/t13-,15+/m1/s1 IMNHEZQIZVJYRU-HIFRSBDPSA-N 481200 6-((5S,8R)-2-(5-Fluoropyridin-2-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyrid in-3-yl)quinoline-4-carboxamide 39-1::US10906905, Example 39-1 Mitogen-activated protein kinase 14 Homo sapiens 4734 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481200&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439632 443550375 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 998241 Cn1cc(cn1)-c1cc(ccn1)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C22H19FN6/c1-28-12-15(10-26-28)19-9-13(6-7-24-19)21-20(18-5-3-16(23)11-25-18)27-22-14-2-4-17(8-14)29(21)22/h3,5-7,9-12,14,17H,2,4,8H2,1H3/t14-,17+/m1/s1 OKJBNDABXTVZHD-PBHICJAKSA-N 481201 (5S,8R)-2-(5-Fluoropyridin-2-yl)-3-(2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 40-1::US10906905, Example 40-1 Mitogen-activated protein kinase 14 Homo sapiens 1362 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481201&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439636 443550376 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 998242 CS(=O)(=O)c1ccc(cc1)-c1cc(ccn1)-c1c(nc2[C@@H]3CC[C@@H](C3)n12)-c1ccc(F)cn1 InChI=1S/C25H21FN4O2S/c1-33(31,32)20-7-3-15(4-8-20)22-13-16(10-11-27-22)24-23(21-9-5-18(26)14-28-21)29-25-17-2-6-19(12-17)30(24)25/h3-5,7-11,13-14,17,19H,2,6,12H2,1H3/t17-,19+/m1/s1 QXSNTBHAJYMYMR-MJGOQNOKSA-N 481210 (5S,8R)-2-(5-Fluoropyridin-2-yl)-3-(2-(4-(methylsulfonyl)phenyl)pyridin-4-yl)-5,6,7,8-tetrahydro-5,8-methanoimidazo[1,2-a]pyridine 42-1::US10906905, Example 42-1 Mitogen-activated protein kinase 14 Homo sapiens 7782 US Patent 10.7270/Q26Q21BC aid1805232 US10906905 Yu, S; Yang, F; Yan, J; Wu, X; He, F; Tao, W 2/2/2021 8/22/2021 Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=481210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=481210&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134439704 443550385 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0